Johnson BE - Search Results

1

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.

Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N, Halmos B, Pearlberg J, Tsuchihashi Z, Cantley LC, Tenen DG, Johnson BE, Jänne PA. Mukohara T, et al. Among authors: johnson be. J Natl Cancer Inst. 2005 Aug 17;97(16):1185-94. doi: 10.1093/jnci/dji238. J Natl Cancer Inst. 2005. PMID: 16106023

2

myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.

Johnson BE, Brennan JF, Ihde DC, Gazdar AF. Johnson BE, et al. J Natl Cancer Inst Monogr. 1992;(13):39-43. J Natl Cancer Inst Monogr. 1992. PMID: 1327035

3

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial.

Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingam JD, Johnson BE, Minna JD, Ihde DC. Gazdar AF, et al. Among authors: johnson be. J Natl Cancer Inst. 1990 Jan 17;82(2):117-24. doi: 10.1093/jnci/82.2.117. J Natl Cancer Inst. 1990. PMID: 2152944 Clinical Trial.

4

Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines.

Bliss DP Jr, Battey JF, Linnoila RI, Birrer MJ, Gazdar AF, Johnson BE. Bliss DP Jr, et al. Among authors: johnson be. J Natl Cancer Inst. 1990 Feb 21;82(4):305-10. doi: 10.1093/jnci/82.4.305. J Natl Cancer Inst. 1990. PMID: 2153841

5

Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies.

Johnson BE, Whang-Peng J, Naylor SL, Zbar B, Brauch H, Lee E, Simmons A, Russell E, Nam MH, Gazdar AF. Johnson BE, et al. J Natl Cancer Inst. 1989 Aug 16;81(16):1223-8. doi: 10.1093/jnci/81.16.1223. J Natl Cancer Inst. 1989. PMID: 2569043

6

MDR1 gene expression in lung cancer.

Lai SL, Goldstein LJ, Gottesman MM, Pastan I, Tsai CM, Johnson BE, Mulshine JL, Ihde DC, Kayser K, Gazdar AF. Lai SL, et al. Among authors: johnson be. J Natl Cancer Inst. 1989 Aug 2;81(15):1144-50. doi: 10.1093/jnci/81.15.1144. J Natl Cancer Inst. 1989. PMID: 2746668

7

The development of small cell lung cancer in the contralateral lung of a patient surviving 8 years after the original diagnosis of small cell lung cancer.

Howard JR Jr, Veach SR, DeVaney K, Walsh T, Cotelingam JD, Johnson BE. Howard JR Jr, et al. Among authors: johnson be. Cancer. 1988 Jul 15;62(2):436-9. doi: 10.1002/1097-0142(19880715)62:2<436::aid-cncr2820620231>3.0.co;2-9. Cancer. 1988. PMID: 2838153

8

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A, Johnson BE. Kelley MJ, et al. Among authors: johnson be. J Natl Cancer Inst. 1995 May 17;87(10):756-61. doi: 10.1093/jnci/87.10.756. J Natl Cancer Inst. 1995. PMID: 7563154

9

Obesity and therapy-related toxicity in patients treated for small-cell lung cancer.

Georgiadis MS, Steinberg SM, Hankins LA, Ihde DC, Johnson BE. Georgiadis MS, et al. Among authors: johnson be. J Natl Cancer Inst. 1995 Mar 1;87(5):361-6. doi: 10.1093/jnci/87.5.361. J Natl Cancer Inst. 1995. PMID: 7853417 Clinical Trial.

10

Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival.

Winter SF, Sekido Y, Minna JD, McIntire D, Johnson BE, Gazdar AF, Carbone DP. Winter SF, et al. Among authors: johnson be. J Natl Cancer Inst. 1993 Dec 15;85(24):2012-8. doi: 10.1093/jnci/85.24.2012. J Natl Cancer Inst. 1993. PMID: 8246287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters